Cancel anytime
OrganiGram Holdings Inc (OGI)OGI
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: OGI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: -51.33% | Upturn Advisory Performance 1 | Avg. Invested days: 21 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: -51.33% | Avg. Invested days: 21 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 205.36M USD |
Price to earnings Ratio - | 1Y Target Price 8.8 |
Dividends yield (FY) - | Basic EPS (TTM) -1.85 |
Volume (30-day avg) 686140 | Beta 1.13 |
52 Weeks Range 0.97 - 2.91 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 205.36M USD | Price to earnings Ratio - | 1Y Target Price 8.8 |
Dividends yield (FY) - | Basic EPS (TTM) -1.85 | Volume (30-day avg) 686140 | Beta 1.13 |
52 Weeks Range 0.97 - 2.91 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -153.8% | Operating Margin (TTM) -12.29% |
Management Effectiveness
Return on Assets (TTM) -5.56% | Return on Equity (TTM) -54.53% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE - | Forward PE 28.99 |
Enterprise Value 146210554 | Price to Sales(TTM) 1.38 |
Enterprise Value to Revenue 1.23 | Enterprise Value to EBITDA 9.27 |
Shares Outstanding 108573000 | Shares Floating 72513548 |
Percent Insiders 31.43 | Percent Institutions 8.4 |
Trailing PE - | Forward PE 28.99 | Enterprise Value 146210554 | Price to Sales(TTM) 1.38 |
Enterprise Value to Revenue 1.23 | Enterprise Value to EBITDA 9.27 | Shares Outstanding 108573000 | Shares Floating 72513548 |
Percent Insiders 31.43 | Percent Institutions 8.4 |
Analyst Ratings
Rating 4.14 | Target Price 8.8 | Buy - |
Strong Buy 4 | Hold 3 | Sell - |
Strong Sell - |
Rating 4.14 | Target Price 8.8 | Buy - | Strong Buy 4 |
Hold 3 | Sell - | Strong Sell - |
AI Summarization
OrganiGram Holdings Inc. (OGI) Stock Overview:
Company Profile:
History and Background:
OrganiGram Holdings Inc. (OGI) is a Canadian licensed producer of cannabis and cannabis-derived products. Founded in 2013 and headquartered in Moncton, New Brunswick, OGI has grown into a mid-tier player in the Canadian cannabis market.
OGI's core business areas include:
- Cultivation and production: OGI operates two indoor cultivation facilities in New Brunswick, with a total annual production capacity of 113,000 kg.
- Product development and manufacturing: OGI offers a range of cannabis products, including dried flower, pre-rolls, oils, edibles, and vapes.
- Distribution and sales: OGI distributes its products through provincial cannabis boards and directly to consumers through its own e-commerce platform.
Leadership Team and Corporate Structure:
OGI's leadership team is led by Beena Goldenberg, CEO and Chair of the Board. The company's corporate structure includes a Board of Directors, an Executive Team, and various functional departments.
Top Products and Market Share:
Top Products:
- Edison Cannabis: OGI's flagship brand, Edison Cannabis, offers a range of dried flower, pre-rolls, and oils.
- Big Bag O' Buds: This brand focuses on value-priced dried flower options.
- LaDiva: This brand caters to the female cannabis consumer with a focus on wellness and relaxation.
Market Share:
OGI holds a ~2% market share of the Canadian cannabis market. The company faces stiff competition from larger players like Canopy Growth and Tilray.
Total Addressable Market:
The global cannabis market is expected to reach USD 176.5 billion by 2030, growing at a CAGR of 22.9% from 2023 to 2030. The US cannabis market is expected to be the largest contributor, with a market size of USD 47.3 billion by 2030.
Financial Performance:
Recent Financial Statements:
- Revenue: Q2 2023: CA$ 16.2 million (YoY decrease of 23%)
- Net Income: Q2 2023: CA$ (2.8) million (YoY decrease of 487%)
- Profit Margin: Q2 2023: (17.3%)
- Earnings per Share (EPS): Q2 2023: CA$ (0.03)
Year-over-Year Performance: OGI's revenue and net income have declined YoY due to increased competition and a challenging market environment.
Cash Flow and Balance Sheet: OGI has a cash balance of CA$ 38.9 million and total debt of CA$ 88.8 million as of Q2 2023. The company's cash flow is negative, and its balance sheet is relatively weak.
Dividends and Shareholder Returns:
OGI does not currently pay dividends. Shareholder returns have been negative in recent years due to the company's declining stock price.
Growth Trajectory:
Historical Growth: OGI has experienced significant growth in its early years, but its growth has slowed recently.
Future Growth Projections: The company expects to achieve positive EBITDA in the second half of 2024.
Recent Growth Initiatives: OGI is focusing on cost reduction, product innovation, and expanding its distribution channels.
Market Dynamics:
Industry Trends: The cannabis industry is rapidly evolving, with increasing legalization, competition, and technological innovation.
Market Position: OGI is a mid-tier player in a competitive market. The company's success will depend on its ability to differentiate its products, optimize its costs, and expand its distribution network.
Competitors:
Key Competitors:
- Canopy Growth Corporation (CGC)
- Tilray Inc. (TLRY)
- Aurora Cannabis Inc. (ACB)
Market Share Comparison:
- Canopy Growth: ~15%
- Tilray: ~10%
- Aurora Cannabis: ~7%
- OrganiGram: ~2%
Competitive Advantages: OGI has a strong brand portfolio, a focus on quality, and a vertically integrated business model.
Competitive Disadvantages: OGI is smaller than its main competitors and has a weaker balance sheet.
Potential Challenges and Opportunities:
Key Challenges:
- Intense competition
- Regulatory uncertainty
- Negative cash flow
- Weak balance sheet
Potential Opportunities:
- Continued growth of the cannabis market
- Product innovation
- Expansion into new markets
- Strategic partnerships
Recent Acquisitions:
OGI has not made any acquisitions in the past 3 years.
AI-Based Fundamental Rating:
Rating: 6/10
Justification: OGI has a strong brand portfolio, a focus on quality, and a vertically integrated business model. However, the company faces significant challenges, including intense competition, regulatory uncertainty, negative cash flow, and a weak balance sheet.
Sources:
- OrganiGram Holdings Inc. website
- Sedar
- Statista
Disclaimer:
The information provided in this overview is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OrganiGram Holdings Inc
Exchange | NASDAQ | Headquaters | Toronto, ON, Canada |
IPO Launch date | 2014-08-27 | CEO & Director | Ms. Beena G. Goldenberg |
Sector | Healthcare | Website | https://www.organigram.ca |
Industry | Drug Manufacturers - Specialty & Generic | Full time employees | 914 |
Headquaters | Toronto, ON, Canada | ||
CEO & Director | Ms. Beena G. Goldenberg | ||
Website | https://www.organigram.ca | ||
Website | https://www.organigram.ca | ||
Full time employees | 914 |
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.